InvestorsHub Logo
Followers 5
Posts 340
Boards Moderated 0
Alias Born 10/15/2014

Re: piranha_trader post# 8285

Saturday, 10/25/2014 6:03:47 PM

Saturday, October 25, 2014 6:03:47 PM

Post# of 27552
Fair question, and I don't think you are bashing.-) As for revenues, it is because it is all tied into what they have in their own pipeline. If you go their website, you will see all of the vaccines they are developing, with partners listed. For biotech companies, in the beginning, there is nothing to report in the way of revenues. However, with the ebola virus, all the game changes, as the govt has requested "all hands on deck". Ibio has stated that they can help by quickly producing the antibodies that go into the vaccines - hence the main component. Any immediate production would clearly mean fresh revenue streams in near-term, not just long term. I personally feel they will be scooped up by one of the big Pharmas, just to get their plant-based technology. Just my opinion, but in my eyes, it makes the most sense for a big pharma that does not have this under their umbrella, since clearly, "plant based" is the future - not animals.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IBIO News